Literature DB >> 20092087

Safer cardiac surgery.

Alan F Merry1.   

Abstract

Safety in cardiac surgery should be evaluated in the context of the other elements of quality in healthcare (timeliness, effectiveness, efficiency, equity, and most importantly, patient-centeredness). Mortality alone is not an adequate index of safety: Stroke is particularly feared by patients and prolonged periods of hospitalization can be very difficult for families to cope with. Advances in knowledge, technology, and medications have improved outcomes, but pharmacological means of reducing cerebral dysfunction after cardiopulmonary bypass remain elusive. Clear differences can be demonstrated between the results of different surgeons and also between different anesthesiologists. The World Health Organization's recently introduced Surgical Safety Checklist provides a validated and inexpensive cognitive aid to reduce human error and improve teamwork and communication in the operating room. Patient selection is very important, and patients should be given clear information on the relative merits of alternative treatments (for example, coronary surgery, percutaneous intervention, and medical treatment in the case of coronary artery disease). In the end, outcomes that the patients themselves desire are the most meaningful endpoint of the pursuit of safer cardiac surgery.

Entities:  

Mesh:

Year:  2009        PMID: 20092087      PMCID: PMC4813534     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  45 in total

1.  Venous air in the bypass circuit: a source of arterial line emboli exacerbated by vacuum-assisted drainage.

Authors:  T W Willcox; S J Mitchell; D F Gorman
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

2.  The use of and preferences for the transesophageal echocardiogram and pulmonary artery catheter among cardiovascular anesthesiologists.

Authors:  Michael J Jacka; Marsha M Cohen; Teresa To; J Hugh Devitt; Robert Byrick
Journal:  Anesth Analg       Date:  2002-05       Impact factor: 5.108

3.  The frequency and nature of drug administration error during anaesthesia.

Authors:  C S Webster; A F Merry; L Larsson; K A McGrath; J Weller
Journal:  Anaesth Intensive Care       Date:  2001-10       Impact factor: 1.669

4.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

5.  How safe are our hospitals?

Authors:  Mary Seddon; Alan Merry
Journal:  N Z Med J       Date:  2002-12-13

6.  Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery.

Authors:  Samer A M Nashef; Francois Roques; Bradley G Hammill; Eric D Peterson; Philippe Michel; Frederick L Grover; Richard K H Wyse; T Bruce Ferguson
Journal:  Eur J Cardiothorac Surg       Date:  2002-07       Impact factor: 4.191

7.  Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study.

Authors:  O Ekre; T Eliasson; H Norrsell; P Währborg; C Mannheimer
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

8.  The learning curve of an academic cardiac surgeon: use of the CUSUM method.

Authors:  R J Novick; L W Stitt
Journal:  J Card Surg       Date:  1999 Sep-Oct       Impact factor: 1.620

9.  Systemic thrombin inhibition by Hirulog does not alter medial smooth muscle cell proliferation and inflammatory activation after vascular injury in the rabbit.

Authors:  R Kranzhöfer; J M Maraganore; R Baciu; P Libby
Journal:  Cardiovasc Drugs Ther       Date:  1999-09       Impact factor: 3.727

10.  Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

View more
  3 in total

1.  Declining in-hospital mortality in patients undergoing coronary bypass surgery in the United States irrespective of presence of type 2 diabetes or congestive heart failure.

Authors:  Mohammad Reza Movahed; Radhakrishnan Ramaraj; Ali Khoynezhad; Mehrnoosh Hashemzadeh; Mehrtash Hashemzadeh
Journal:  Clin Cardiol       Date:  2012-05       Impact factor: 2.882

2.  Teamwork, communication, formula-one racing and the outcomes of cardiac surgery.

Authors:  Alan F Merry; Jennifer Weller; Simon J Mitchell
Journal:  J Extra Corpor Technol       Date:  2014-03

3.  To do or not to do?--How people make decisions.

Authors:  Alan F Merry
Journal:  J Extra Corpor Technol       Date:  2011-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.